I agree that this site is using cookies. You can find further informations here.
X
Peer, Cody J
257  results:
Online X
Search for persons X
?
1

Distinct uptake and elimination profiles for trastuzumab, h..:

Silvestri, Vanesa L ; Tran, Andy D ; Chung, Monika...
Neuro-Oncology.  26 (2024)  6 - p. 1067-1082 , 2024
Link: https://doi.org/10.1093/..
 
?
2

BSBM-13 DISTINCT UPTAKE AND ELIMINATION PROFILES FOR TRASTU..:

Silvestri, Vanesa ; Tran, Andy ; Chung, Monika...
Neuro-Oncology Advances.  6 (2024)  Supplement_1 - p. i4-i4 , 2024
Link: https://doi.org/10.1093/..
 
?
3

Pharmacogenomic Variation May Impact Cyclophosphamide Metab..:

Zeng, Yi ; Arisa, Oluwatobi ; Peer, Cody J....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S457 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Tofacitinib to prevent anti-drug antibody formation against..:

Skorupan, Nebojsa ; Peer, Cody J. ; Zhang, Xianyu...
Frontiers in Oncology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
5

Determination of metarrestin (ML-246) in human plasma for a..:

Richardson, William J. ; Zimmerman, Sara M. ; Reno, Annieka...
Journal of Chromatography B.  1224 (2023)  - p. 123738 , 2023
Link: https://doi.org/10.1016/..
 
?
6

EXTH-56. CSF PENETRATION COMPARISON OF TWO ORAL FORMULATION..:

Cabanas, Natalia Corvalan ; McCully, Cynthia Lester ; Peer, Cody...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v237-v237 , 2023
Link: https://doi.org/10.1093/..
 
?
7

ABCL-187 Phase 2 Response-Adapted Study of Ibrutinib With T..:

Simard, Jillian ; Phelan, James D ; Melani, Christopher...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S424-S425 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Preclinical Evaluation of the FGFR-Family Inhibitor Futibat..:

Wu, Jerry T. ; Cheuk, Adam ; Isanogle, Kristine...
Cancers.  15 (2023)  16 - p. 4034 , 2023
Link: https://doi.org/10.3390/..
 
?
9

TRLS-02. FEASIBILITY OF EVALUATING ABEMACICLIB NEUROPHARMAC..:

Jackson, Sadhana ; Glod, John ; Peer, Cody...
Neuro-Oncology.  25 (2023)  Supplement_1 - p. i79-i79 , 2023
Link: https://doi.org/10.1093/..
 
?
10

POSTER: ABCL-187 Phase 2 Response-Adapted Study of Ibrutini..:

Simard, Jillian ; Phelan, James D ; Melani, Christopher...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S205 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Glycemia and Gluconeogenesis With Metformin and Liraglutide..:

Dietsche, Katrina B ; Magge, Sheela N ; Dixon, Sydney A...
The Journal of Clinical Endocrinology & Metabolism.  109 (2023)  5 - p. 1361-1370 , 2023
Link: https://doi.org/10.1210/..
 
?
12

Baricitinib for Refractory Chronic Graft-Versus-Host Diseas..:

Holtzman, Noa G. ; Im, Dr. Annie P. ; Ostojic, Alen...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S251-S252 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Correction: First-in-human phase 1 clinical trial of anti-c..:

Cole, Christopher B. ; Morelli, Maria Pia ; Fantini, Massimo...
Journal of Experimental & Clinical Cancer Research.  42 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
14

Clinical protocol: Feasibility of evaluating abemaciclib ne..:

Nduom, Edjah K. ; Glod, John ; Brown, Desmond A....
PLOS ONE.  18 (2023)  9 - p. e0291068 , 2023
Link: https://doi.org/10.1371/..
 
?
15

In Silico Re‐Optimization of Atezolizumab Dosing Using Popu..:

Peer, Cody J. ; Schmidt, Keith T. ; Arisa, Oluwatobi...
The Journal of Clinical Pharmacology.  63 (2023)  6 - p. 672-680 , 2023
Link: https://doi.org/10.1002/..
 
1-15